Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.903
+0.043 (4.85%)
Nov 21, 2024, 10:39 AM EST - Market open
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $54.42 million as of November 21, 2024. Its market cap has increased by 7.30% in one year.
Market Cap
54.42M
Enterprise Value
-47.21M
1-Year Change
7.30%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $54.42M, a decrease of -94.57%. That is a compound annual growth rate of -50.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 51.25M | -29.69% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytosorbents | 52.47M |
| Vor Biopharma | 52.34M |
| Precision BioSciences | 51.79M |
| Lucid Diagnostics | 51.60M |
| OptiNose | 51.10M |
| Unicycive Therapeutics | 50.34M |
| BGM Group | 49.69M |
| vTv Therapeutics | 49.46M |